Chemours Faces Securities Fraud Class Action Over Refrigerant Demand Overstatement
Oct 20, 2026
Chemours faces securities fraud class action alleging overstated refrigerant demand, resulting in an EBITDA cut and 18.63% stock decline. Investors purchasing shares between February and August 2026 have until December 7, 2026, to file lead plaintiff applications.
Show all 32 updates